Covered stent and stent system
By using the design of corrugated support frame and development marks in the coated stent system, the problem of insufficient positioning accuracy of coated stents is solved, and the vascular remodeling effect and blood flow smoothness of intraluminal treatment are improved.
Patent Information
- Application Number
- CN202420286798.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Priority Date
- 2023-06-06
- Filing Date
- 2024-02-06
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2034-02-06
AI Technical Summary
In intraluminal treatment, the positioning accuracy of the coated stent is insufficient, which makes it difficult for bare metal stents to accurately connect and apply the true cavity, affecting the effect of thrombosis and vascular reconstruction.
A coated bracket system was designed, including the main coating and multiple supporting frames. The support frame is a corrugated structure. The development mark is located in the support wave valley of the supporting frame, which improves the positioning accuracy and adherence of the coated bracket and reduces the Risk of obstruction of branched blood vessels.
It improves the positioning accuracy and adherence of the coated stent, reduces the risk of branched vascular obstruction, enhances blood flow smoothness in the vascular lumen, and promotes thrombosis and vascular remodeling.
Smart Images

Figure CN221998096U_ABST
Abstract
Description
[0001] This application is based on the application with CN application number 2023214330073 and application date 2023-6-6, and claims its priority. The disclosed content of the CN application is hereby introduced into this application as a whole. Technical Field
[0002] The present application relates to the field of medical devices, and in particular to a coated stent and a stent system. Background Art
[0003] Endovascular treatment is one of the main methods for treating peripheral vascular diseases. Endovascular treatment includes EVAR (endovascular aneurysm repair, EVAR) or TEVAR (thoracic endovascular aortic repair, TEVAR). Endovascular treatment refers to the use of corresponding interventional instruments to radially compress the stent graft under the monitoring of imaging equipment, and then deliver it to the location of vascular lesions and release it, so that the stent graft can return to the predetermined shape. The implanted stent graft can support the diseased vascular segment, so that blood flows through the stent graft to restore the correct flow direction of the blood vessel, maintain smooth blood flow in the vascular lumen, and thus achieve the treatment effect. For Stanford type B aortic dissection, the intimal rupture is located below the isthmus of the aorta, extending to the descending aorta or extending to the abdominal aorta. Usually, surgical reconstruction is performed with a proximal aortic repair-based plan, which can only close the proximal tear. Usually, complete false lumen thrombosis can only be observed near the proximal stent graft, while part of the false lumen in the thoracic aorta or abdominal aorta still has not been thrombotic.
[0004] Intravascular treatment provides a PETTICOAT technology to solve the problem of partial false lumen in the thoracic or abdominal aorta that has not been thrombosed. That is, on the basis of the proximal covered stent, a long bare metal stent is connected to the distal end of the covered stent. The radial support force of the bare metal stent can expand the true lumen, compress the false lumen, reduce the risk of further tearing of the distal rupture, and ultimately improve aortic remodeling, thereby promoting thrombusization of the distal false lumen of the thoracic and abdominal aorta and achieving a good true lumen remodeling effect.
[0005] The accurate release of the covered stent affects the positioning accuracy of the bare metal stent, which may make it difficult to determine how the bare metal stent is connected to the covered stent, may cause the covered stent to cut off branch vessels, or may make it difficult for the bare metal stent to better cover the true lumen to compress the false lumen. Utility Model Content
[0006] In order to better improve the positioning accuracy of the coated stent, the present application provides a coated stent and a stent system.
[0007] The present application provides a stent graft, the stent graft comprising a main body graft, the main body graft comprising a proximal opening, a distal opening and an axially extending inner cavity;
[0008] A plurality of support frames, wherein the plurality of support frames are sequentially spaced apart along the axial direction of the main body coating;
[0009] The support skeleton comprises a plurality of support rods connected in sequence at an angle, two adjacent angles in the circumferential direction are a support crest and a support trough respectively, the support crest and the support trough are alternately arranged along the circumference of the support skeleton, and the support crest is closer to the proximal end of the stent graft than the support trough;
[0010] The support frame located at the proximal end of the stent graft is named as the first frame, at least the support trough on the first frame is fixed to the proximal end of the main body graft, and at least the support crest on the first frame extends out of the proximal end of the main body graft in a direction away from the main body graft;
[0011] The first developing structure comprises at least one developing mark, at least one of the developing marks is located and fixed on the proximal side of the supporting wave valley of the first skeleton, and at least one of the developing marks is located in the area surrounded by the supporting wave valley of the first skeleton.
[0012] The present application has at least one of the following beneficial effects: for situations where the root opening size of a branch vessel is small or the distance between two adjacent branch vessels is close, resulting in a small anchoring length that can be provided, a higher requirement for positioning accuracy is placed, and the arrangement of the development mark within the area surrounded by the support trough of the first skeleton can better meet the target vessel's stringent requirements for positioning accuracy, which helps to avoid the coated stent from excessively blocking the root opening of the branch vessel and affecting the blood supply of the branch vessel. BRIEF DESCRIPTION OF THE DRAWINGS
[0013] Figure 1 A schematic structural diagram of a support system according to a first embodiment of the present application;
[0014] Figure 2 This is a schematic structural diagram of a stent graft according to an embodiment;
[0015] Figure 3 for Figure 2 A planar unfolded view of the stent graft shown;
[0016] Figure 4 for Figure 3 An enlarged structural schematic diagram of point A is shown;
[0017] Figure 5 for Figure 3 An enlarged schematic diagram of the structure at B is shown;
[0018] Figure 6 is a schematic diagram of an exemplary structure of a bare stent according to an embodiment;
[0019] Figure 7 for Figure 6 A planar unfolded view of the bare stent shown;
[0020] Figure 8 for Figure 6 A plan view of another possible implementation of a bare stent is shown;
[0021] Fig. 9 The figure is a schematic diagram of an exemplary scenario in which a stent system according to an embodiment is used to reconstruct the thoracic aorta and the abdominal aorta.
[0022] Description of the accompanying drawings: 10, coated stent; 11, main body coating; 12, support frame; 1201, first frame; 1202, second frame; 1203, third frame; 1204, first support ring; 1205, second support ring; 1206, third support ring; 121, support rod; 122, support crest; 123, support trough; 13, first development structure; 14, second development structure; 20, bare stent; 21, support member; 211, first crest; 21 2. Second wave peak; 22. Connector; 221. Connecting section; 222. First connecting portion; 223. Second connecting portion; 23. Grid unit; 24. Keel; 25. Third imaging structure; 30. Brachiocephalic artery; 40. Left common carotid artery; 50. Left clavicular artery; 60. Left renal artery; 70. Right renal artery; 80. Mesenteric artery; 90. Celiac artery; 100. Aneurysm cavity; 101. True cavity; 102. False cavity; 103. Proximal rupture; 104. Distal rupture. DETAILED DESCRIPTION
[0023] The technical solution of the present application will be described clearly and completely below in conjunction with the accompanying drawings. Obviously, the described embodiments are part of the embodiments of the present application, rather than all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present application.
[0024] It should be noted in advance that for the field of interventional medical devices, the proximal end refers to the end of the stent that is close to the heart after the stent is used for interventional treatment, and the distal end refers to the end of the stent that is away from the heart after the stent is used for interventional treatment. The direction of the central axis of rotation of objects such as cylinders and tubes is axial, and the direction perpendicular to the axial direction is radial. The circumferential direction refers to the "circumferential direction", that is, the direction around the axis of the cylinder, tube, etc. (perpendicular to the axis and perpendicular to the cross-sectional radius). "Circumferential", "axial" and "radial" together constitute the three orthogonal directions of the cylindrical coordinates. The circumferential length refers to the extension length of the structure or element along the circumferential direction of the cylinder, tube, etc. The axial length refers to the extension length of the structure or element along the axial direction of the cylinder, tube, etc. In order to distinguish it from the axial length of the support rod itself, the length it occupies in the axial direction of the main stent is referred to as the length along the axial direction of the main stent. This description is only for the convenience of expression and does not constitute a limitation on this application.
[0025] In order to better improve the positioning accuracy of the stent graft, the present application provides a stent graft and a stent system, which can be applied to a blood vessel for intracavitary treatment. It can be understood that the blood vessel can be an aortic arch, a thoracic aorta or an abdominal aorta, etc. A person of ordinary skill in the art should know that the use of a blood vessel for illustration is only used as an example and is not a limitation of the present application. The scheme of the present application is applicable to various human or animal cavities, such as the digestive tract, etc.
[0026] See also Figure 1 , Figure 1 It is a structural schematic diagram of the support system of the first embodiment of the present application.
[0027] The first embodiment of the present application provides a stent system, which includes a coated stent 10 and a bare stent 20, wherein the bare stent 20 is connected to the distal end of the coated stent 10. The distal end of the coated stent 10 and the proximal end of the bare stent 20 have an axial overlapping length. The distal end of the coated stent 10 is located in the inner cavity of the bare stent 20; or the distal end of the coated stent 10 is located outside the bare stent 20, in other words, the proximal end of the bare stent 20 is located in the inner cavity of the coated stent 10.
[0028] The coated stent 10 and the bare stent 20 are of equal-diameter structure or non-equal-diameter structure. In other words, the radial dimensions of the coated stent 10 and the bare stent 20 in the length direction can be the same, or the coated stent 10 and the bare stent 20 are of tapered tubular structure, so that the radial dimensions of the coated stent 10 and the bare stent 20 in the length direction are different.
[0029] See also Figure 2 and Figure 3 , Figure 2 is a schematic structural diagram of a stent graft 10 according to an embodiment, Figure 3 for Figure 2 A plan view of the unfolded coated stent 10 is shown.
[0030] The coated stent 10 includes a proximal opening, a distal opening, and an axially extending inner cavity, and the coated stent 10 is a self-expanding stent. The coated stent 10 includes a main body coating 11 and a plurality of support frames 12 fixed to the main body coating 11, and the plurality of support frames 12 are sequentially spaced along the axial direction of the main body coating 11. The bare stent 20 includes a proximal opening, a distal opening, and an axially extending inner cavity, and the bare stent 20 is a self-expanding stent, and the bare stent 20 is not covered by the main body coating 11.
[0031] The support skeleton 12 is a wave-shaped structure, and the support skeleton 12 includes a plurality of support rods 121 connected in sequence at an angle. The two adjacent angles in the circumferential direction are the support crest 122 and the support trough 123, respectively, and the support crest 122 and the support trough 123 are arranged alternately along the circumference of the support skeleton 12. The support crest 122 on the stent graft 10 is closer to the proximal end of the stent graft 10 than the support trough 123.
[0032] It can be understood that the angle can be a chamfer, that is, the angle can be arc-shaped.
[0033] For easy distinction, the multiple support skeletons 12 located at the proximal end of the coated stent 10 are named the first skeleton 1201, the second skeleton 1202 and the third skeleton 1203 in sequence. The first skeleton 1201, the second skeleton 1202 and the third skeleton 1203 are arranged in sequence from the proximal end to the distal end of the main coating 11.
[0034] In some embodiments, there are still multiple supporting skeletons 12 on the distal side of the third skeleton 1203.
[0035] The multiple support skeletons 12 located at the distal end of the coated stent 10 are named as the first support circle 1204, the second support circle 1205 and the third support circle 1206 in sequence. The first support circle 1204, the second support circle 1205 and the third support circle 1206 are arranged in sequence from the distal end to the proximal end of the main body coating 11.
[0036] In some embodiments, there are still multiple support skeletons 12 between the distal side of the third skeleton 1203 and the proximal side of the third support ring 1206.
[0037] At least the supporting trough 123 on the first skeleton 1201 is fixed to the proximal end of the main body coating 11 , and at least the supporting crest 122 on the first skeleton 1201 extends out of the proximal end of the main body coating 11 in a direction away from the main body coating 11 .
[0038] In some embodiments, the support trough 123 on the first skeleton 1201 and the local length of the distal end of the support rod 121 are fixed to the proximal end of the main body coating 11, and the local length of the support rod 121 and the support crest 122 extend out of the proximal end of the main body coating 11 in a direction away from the main body coating 11, so that the support trough 123 on the first skeleton 1201 and the local length of the support rod 121 are covered by the main body coating 11, while the support crest 122 on the first skeleton 1201 and the local length of the support rod 121 are not covered by the main body coating 11.
[0039] At least part of the supporting crests 122 on the first skeleton 1201 are used to be detachably hooked on the interventional instrument. After radial compression, the stent graft 10 is detachably hooked on the interventional instrument through the first skeleton 1201. The interventional instrument delivers the compressed stent graft 10 to the location of the vascular lesion and then releases it to restore the stent graft 10 to a predetermined shape. The implanted stent graft 10 supports the diseased blood vessel segment, allowing blood to flow through the stent graft 10 to restore the correct flow direction of the blood vessel, maintain smooth blood flow in the vascular lumen, and thereby achieve a therapeutic effect.
[0040] In some embodiments, the support crests 122 of the second skeleton 1202 and the support crests 122 of the first skeleton 1201 are axially opposite to each other, and the support troughs 123 of the second skeleton 1202 and the support troughs 123 of the first skeleton 1201 are axially opposite to each other, so that the proximal wall adhesion of the coated stent 10 is improved, and the anti-internal leakage effect of the proximal end of the coated stent 10 is better improved, which is beneficial to reduce the circumferential or axial displacement of the coated stent 10.
[0041] In some embodiments, the circumferential length between two circumferentially adjacent support troughs 123 of the third skeleton 1203 is smaller than the circumferential length between two circumferentially adjacent support troughs 123 of any other support skeleton 12, and the circumferential length between two circumferentially adjacent support crests 122 of the third skeleton 1203 is smaller than the circumferential length between two circumferentially adjacent support crests 122 of any other support skeleton 12, thereby improving the wall adhesion of the proximal end of the coated stent 10, better reducing the risk of internal leakage at the proximal end of the coated stent 10, and helping to further reduce the circumferential or axial displacement of the coated stent 10.
[0042] In some embodiments, the distal side of any supporting crest 122 of the second skeleton 1202 corresponds to at least two supporting crests 122 of the third skeleton 1203 , which improves the wall adhesion of the proximal end of the coated stent 10 and better reduces the risk of internal leakage at the proximal end of the coated stent 10 .
[0043] In some embodiments, the first support ring 1204, the second support ring 1205 and the third support ring 1206 are equal-height waves. In other words, the multiple support wave crests 122 on the first support ring 1204 are located in the circumferential plane of the same main body coating 11, and the multiple support wave troughs 123 on the first support ring 1204 are located in the circumferential plane of the same main body coating 11. Similarly, the second support ring 1205 and the third support ring 1206 are not described here. This arrangement is conducive to improving the radial support force of the distal end of the coated stent 10, improving the wall adhesion of the distal end of the coated stent 10, and is conducive to reducing the circumferential or axial displacement of the coated stent 10.
[0044] In some embodiments, the plurality of support skeletons 12 between the distal side of the third skeleton 1203 and the proximal side of the third support ring 1206 are arranged in high and low waves. In other words, for the same support skeleton 12 between the distal side of the third skeleton 1203 and the proximal side of the third support ring 1206, the support wave crests 122 thereon include high waves and low waves, and the high waves and low waves are arranged alternately along the circumference of the main body coating 11. The proximal end of the high wave extends beyond the proximal end of the low wave, and the proximal end of the high wave is closer to the proximal end of the main body coating 11 than the proximal end of the low wave; or, the axial length of the support rod 121 forming the high wave is greater than the axial length of the support rod 121 forming the low wave. For two axially adjacent support skeletons 12, the high wave and the low wave are opposite, which is conducive to improving the flexibility of the middle section of the coated stent 10 and better adapting to the complex and twisted vascular anatomical morphology.
[0045] Please refer to Figure 3 and Figure 4 , Figure 4 for Figure 3 A schematic diagram of the enlarged structure shown.
[0046] In one or more embodiments, the stent graft 10 further includes a first development structure 13, which is located and fixed to the proximal end of the main graft 11. The first development structure 13 includes at least one development mark.
[0047] In one or more embodiments, the first developing structure 13 includes at least two developing marks, and the at least two developing marks are arranged at intervals along the circumference of the main body film 11. Further, the at least two developing marks are arranged at even intervals along the circumference of the main body film 11.
[0048] In one or more embodiments, the first developing structure 13 includes at least three developing marks, and the at least three developing marks are arranged at intervals along the circumference of the main body film 11. Further, the at least three developing marks are arranged at even intervals along the circumference of the main body film 11.
[0049] In some embodiments, a plurality of development marks are evenly spaced along the circumference of the main body coating 11 .
[0050] The development mark is located in the area surrounded by the support trough 123 of the first skeleton 1201. The development mark is located on the proximal side of the support trough 123 of the first skeleton 1201. Compared with the remaining areas of the first skeleton 1201, such as the distal side of the support crest 122 of the first skeleton 1201, that is, the area of the main coating 11 between two circumferentially adjacent support troughs 123 of the first skeleton 1201, setting the development mark on the proximal side of the support trough 123 of the first skeleton 1201 is beneficial to reducing the possibility of axial displacement or circumferential displacement of the development mark, thereby improving the positioning accuracy of the coated bracket 10.
[0051] The developing mark is located in the area surrounded by the support trough 123 of the first skeleton 1201. The developing mark is located on the proximal side of the support trough 123 of the first skeleton 1201. Compared with being located in the area surrounded by the support peak 122 on the second skeleton 1202, setting the developing mark on the proximal side of the support trough 123 of the first skeleton 1201 can reduce the positioning error of the proximal end of the main body coating 11 and minimize the degree to which the main body coating 11 blocks the root opening of the branch blood vessels.
[0052] In particular, when the root opening of a branch vessel is small or the distance between two adjacent branch vessels is close, resulting in a small anchoring length that can be provided, a higher requirement for positioning accuracy is placed. The arrangement of the development mark within the area surrounded by the support trough 123 of the first skeleton 1201 can better meet the stringent requirements of the target vessel for positioning accuracy, and is conducive to avoiding the coated stent 10 from excessively blocking the root opening of the branch vessel and affecting the blood supply of the branch vessel.
[0053] In some embodiments, the developing mark is fixed to the main body covering 11 by sutures.
[0054] In some embodiments, the proximal end of the development mark is flush with the proximal end of the main body coating 11. The flushness of the development mark with the proximal end of the main body coating 11 allows a fixed error or measurement error of ±10%.
[0055] In some embodiments, the development mark is at least partially fixed to the supporting trough 123 of the first skeleton 1201 by sutures. Combined with the fact that the development mark is located in the area surrounded by the supporting trough 123, the structural stability of the development mark is further improved, making the development mark more firmly fixed, and also helping to reduce the displacement and deformation of the development mark.
[0056] In some embodiments, the shape of the development mark is an "8" shape. Compared with other shapes (such as an I shape), the "8"-shaped development shape is conducive to more firmly fixing the development mark on the main body coating 11, thereby reducing the risk of displacement of the development mark; at the same time, compared with other shapes (such as an I shape), this shape is conducive to reducing the puncture of the main body coating 11 or reducing the stimulation to the blood vessel wall; in addition, even if the coated stent 10 is radially compressed and assembled in the interventional device, the "8"-shaped development shape is not easy to deform, and its stable structure facilitates the judgment of the relevant position of the coated stent 10 in the interventional device, better indicates the operator's operation, and improves the operation accuracy and efficiency.
[0057] In some embodiments, the length direction of the "8"-shaped development mark is set along the length direction of the coated stent 10. In other words, the "8" shape is set vertically rather than horizontally (vertical means parallel to the length direction of the coated stent 10). This setting method is convenient for judging whether the inclination angle of the coated stent 10 in the complex and twisted target blood vessel meets the expected setting. If it does not meet the expectations, the angle of the proximal end of the coated stent 10 can be adjusted until it meets the expectations by judging whether the proximal or distal ends of at least two development marks or at least three development marks are located in the required horizontal plane. It can be understood that this kind of flushing allows a fixed error or measurement error of ±10%.
[0058] In some embodiments, the "8"-shaped developing mark is formed by winding the same developing wire. Compared with the solution of forming the "8" shape by splicing two "o" shapes, this solution is more firmly fixed and reduces the displacement of the developing mark.
[0059] Please refer to Figure 3 , Figure 4 and Figure 5 , Figure 5 for Figure 3 Schematic diagram of the enlarged structure at point B shown.
[0060] In one or more embodiments, the stent graft 10 further includes a second visualization structure 14, which is located and fixed at the distal end of the stent graft 10. The second visualization structure 14 includes at least two columns of visualization marks, which are arranged at intervals along the circumference of the stent graft 10.
[0061] By setting at least two columns of developing marks, whether the connection point between the proximal end of the bare stent 20 and the distal end of the coated stent 10 is judged by observing whether the proximal ends of the at least two columns of developing marks are flush or whether the distal ends are flush, it is helpful to avoid the proximal end of the bare stent 20 from being obliquely inserted into the distal end of the coated stent 10, thereby improving the positioning accuracy of the bare stent 20.
[0062] In some embodiments, the length direction of each column of developing marks is set along the length direction of the main body coating 11. The axial length of each column of developing marks is 30-50mm. The setting of the axial length of the developing marks is conducive to observing whether the overlapping length between the bare stent 20 and the coated stent 10 meets expectations. At the same time, this overlapping length setting has a longer anchoring distance than the general overlapping stent, which is conducive to the bare stent 20 being more firmly connected to the distal end of the coated stent 10, and is conducive to reducing the shortening rate of the bare stent 20; at the same time, in some embodiments, this overlapping length setting is also conducive to limiting the excessive expansion of the coated stent 10, and is conducive to preventing the edge of the coated stent 10 from damaging the aortic intima, thereby reducing the incidence of new distal ruptures.
[0063] In some embodiments, the axial length of each column of developing markers covers at least two supporting skeletons 12 at the distal end of the coated stent 10 .
[0064] In some embodiments, the axial length of each column of developing markers covers 2-3 supporting skeletons 12 at the distal end of the coated stent 10.
[0065] Each column of development marks includes at least two development points, and the length direction of the line connecting the center positions of multiple development points in the same column of development marks is set along the length direction of the coated support 10.
[0066] In some embodiments, for at least two developing points on the same row of developing marks, at least one of the developing points is located at the distal side of a supporting crest 122 of the first supporting circle 1204, and the developing point is fixed to the distal end of the main body covering 11 by sutures, and the distal end of the developing point is flush with the distal end of the main body covering 11, which is conducive to reducing the overlap error between the proximal end of the bare stent 20 and the distal end of the covered stent 10, and improving the release accuracy of the bare stent 20. It can be understood that the flushing of the developing point with the distal end of the main body covering 11 allows a fixed error or measurement error of ±10%.
[0067] In some embodiments, the length direction of at least one row of development marks and the connecting line of at least one development mark are parallel to the length direction of the main coating 11. It is understood that such parallelism allows a fixed error or measurement error of ±10%.
[0068] In some embodiments, for at least two developing points on the same column of developing marks, at least one of the developing points is located on the distal side of a support crest 122 of the first support ring 1204, and at least another developing point is located on the distal side of the support crest 122 of the third support ring 1206. The axial length between the two developing points serves to indicate the overlapping length between the bare stent 20 and the coated stent 10, thereby better improving the positioning accuracy of the coated stent 10 and the bare stent 20.
[0069] In some embodiments, the developing point is in the shape of a ring. Compared with other shapes (such as an I-shape), the ring shape is conducive to more firmly fixing the developing mark on the main body coating 11, thereby reducing the risk of displacement of the developing mark; at the same time, compared with other shapes (such as an I-shape), the ring shape is conducive to reducing the occurrence of puncturing the main body coating 11 or reducing stimulation to the blood vessel wall; in addition, the manufacturing process of the ring shape is simpler, thereby improving production efficiency; in addition, even if the bare stent 20 is radially compressed and assembled in the interventional device, the ring shape is not easy to deform, and its stable structure facilitates the judgment of the relevant position of the bare stent 20 in the interventional device, thereby better indicating the operator's operation.
[0070] The bare stent 20 includes a plurality of support frames 12, which are sequentially connected along the axial direction, so that the bare stent 20 forms a proximal opening, a distal opening, and an axially extending inner cavity. The support crest 122 on the bare stent 20 is closer to the proximal end of the bare stent 20 than the support trough 123.
[0071] The plurality of support frames 12 include a plurality of support members 21 and a plurality of connecting members 22. The plurality of support members 21 are arranged at intervals along the axial direction of the bare stent 20. The connecting members 22 are connected and fixed to two axially adjacent support members 21.
[0072] See also Figure 6 and Figure 7 , Figure 6 FIG. 2 is a schematic diagram of an exemplary structure of a bare stent 20 according to an embodiment of the present invention. Figure 7 for Figure 6 A plan view of the bare stent 20 is shown.
[0073] For the bare stent 20, among two axially adjacent support members 21, the support crest 122 of the support member 21 near the proximal end and the support trough 123 of the support member 21 near the distal end are axially opposite, or the support crest 122 of the support member 21 near the proximal end and the support crest 122 of the support member 21 near the distal end are axially opposite.
[0074] The connector 22 is a wave-shaped structure, and includes a plurality of connecting segments 221 connected at an angle, and the plurality of connecting segments 221 are connected in sequence at an angle. The two adjacent angles in the circumferential direction are respectively the first connecting portion 222 and the second connecting portion 223, and the first connecting portion 222 and the second connecting portion 223 are arranged alternately along the circumference of the connector 22. The first connecting portion 222 is closer to the proximal end of the bare stent 20 than the second connecting portion 223.
[0075] In two axially adjacent support members 21, the first connection portion 222 of the connector 22 is fixed to the support trough 123 of the support member 21 near the proximal end by one or more methods of winding, knotting, welding, hot pressing, bonding, mechanical fixation (such as steel sleeve) and suture suturing, and the second connection portion 223 of the connector 22 is fixed to the support crest 122 of the support member 21 near the distal end by one or more methods of winding, knotting, welding, hot pressing, bonding, mechanical fixation (such as steel sleeve) and suture suturing. The angle arrangement position between the support member 21 and the connector 22 enables the bare stent 20 to form a grid structure with grid units 23.
[0076] In some other embodiments, the grid unit 23 is in a rhombus shape.
[0077] In some other embodiments, the connector 22 is a wave-shaped structure, and for the same support member 21, part of the support crests 122 and / or part of the support troughs 123 are not connected to the connector 22. In other words, for the same support member 21, part of the support crests 122 and / or part of the support troughs 123 may be in a suspended state. For example, the length of some connecting segments 221 on the connector 22 is relatively long, so that part of the support crests 122 and / or part of the support troughs 123 can be fixed to another support crest 122 or support trough 123 along the circumferential interval, so that part of the support crests 122 and / or part of the support troughs 123 are in a suspended state. The existence of the suspended state is conducive to increasing the blood supply to the visceral arteries, reducing the risk of the bare stent 20 obstructing the blood supply to the visceral arteries, and improving the flexibility of the bare stent 20.
[0078] For the support member 21 located at the proximal end of the bare stent 20, the support crest 122 on the proximal support member 21 includes a plurality of first crests 211 and at least one second crest 212, and the axial length of the support rod 121 forming the second crest 212 is longer than the axial length of the support rod 121 forming the first crest 211. The proximal end of the second crest 212 is farther away from the distal end of the bare stent 20 than the proximal end of the first crest 211, in other words, the proximal end of the second crest 212 extends in the direction of the proximal end of the bare stent 20 beyond the proximal end of the first crest 211.
[0079] In some embodiments, the number of the second wave crests 212 is at least three, and along the circumference of the bare stent 20, one or more first wave crests 211 are spaced between two adjacent second wave crests 212. It can be understood that one or more first wave crests 211 are spaced between two adjacent second wave crests 212, and the same number of first wave crests 211 may be spaced between any two adjacent second wave crests 212, or different numbers of first wave crests 211 may be spaced between any two adjacent second wave crests 212, or the number of first wave crests 211 spaced between at least two adjacent second wave crests 212 may be different from the number between any other two adjacent second wave crests 212, and so on.
[0080] The second wave crest 212 is used to be detachably hooked on the interventional instrument. After radial compression, the bare stent 20 is detachably hooked on the interventional instrument through the second wave crest 212. The interventional instrument delivers the compressed bare stent 20 to the location of the vascular lesion and then releases it to restore the bare stent 20 to a predetermined shape. The implanted bare stent 20 can support the diseased blood vessel segment, allowing blood to flow through the bare stent 20 to restore the correct flow direction of the blood vessel, maintain smooth blood flow in the vascular lumen, and thereby achieve a therapeutic effect.
[0081] In some embodiments, for the support skeleton 12 located at the proximal end of the bare stent 20, at least one support crest 122 thereon is provided with a third developing structure 25, and the shape of the third developing structure 25 is an inverted "V" shape to adapt to the shape of the support crest 122.
[0082] In some embodiments, the third developing structure 25 is disposed on at least one second wave crest 212. The shape of the third developing structure 25 is an inverted "V" shape to adapt to the shape of the second wave front 212. The third developing structure 25 is used to indicate the position of the proximal end of the bare stent 20, better align with the target position at the distal end of the coated stent 10, improve the accuracy of the overlapping length between the bare stent 20 and the coated stent 10, and better improve the positioning accuracy of the bare stent 20.
[0083] During the release of the stent system, under the irradiation of the imaging device, the developing structures in the coated stent 10 and the bare stent 20 are projected onto a plane perpendicular to the irradiation angle and can be observed by the operator.
[0084] The first developing structure 13, the second developing structure 14 and the third developing structure 25 are made of materials with good X-ray opacity, strong corrosion resistance and good biocompatibility, and can be gold, platinum, tantalum, osmium, rhenium, tungsten, iridium, rhodium and other materials or alloys of these materials.
[0085] In some embodiments, the first developing structure 13, the second developing structure 14 and / or the third developing structure 25 can be understood as: the first developing structure 13, the second developing structure 14 and the third developing structure 25 are made of developing materials, or silk threads made of developing materials are fixed on rod-shaped bodies of the shapes of the first developing structure 13, the second developing structure 14 and / or the third developing structure 25 by one or more methods of winding, knotting, welding, hot pressing, bonding, mechanical fixation (such as steel sleeves) and suture thread suturing.
[0086] The bare stent 20 also includes at least one row of positioning ribs, each row of positioning ribs includes at least one keel 24, and at least one keel 24 is fixed to the proximal end of the bare stent 20. The two ends of the keel 24 in the length direction are respectively fixed to the support rods 121 of the two support members 21, and the fixing method can be one or more of winding, knotting, welding, hot pressing, bonding, mechanical fixation (such as steel sleeve) and suture thread suturing. The support members 21 where the two ends of the keel 24 in the length direction are located are adjacent along the axial direction of the bare stent 20; or there is at least one support member 21 between the two ends of the keel 24 in the length direction (excluding the support members 21 where the two ends of the keel 24 in the length direction are located).
[0087] In some embodiments, two ends of the keel 24 in the length direction are respectively fixed to the middle of the length direction of the support rods 121 on the two support members 21 .
[0088] In some embodiments, the keel 24 is located at the distal end or middle portion of the bare stent 20 .
[0089] In some embodiments, the length direction of the keel 24 extends along the length direction of the bare stent 20; or the length direction of the keel 24 and the length direction of the bare stent 20 have an angle, in other words, the keel 24 is fixed on the bare stent 20 at an angle.
[0090] In one or more embodiments, the bare stent 20 includes at least one row of positioning ribs, each row of positioning ribs includes at least two keels 24, at least two keels 24 are arranged at intervals along the axial direction of the bare stent 20, and at least two keels 24 are respectively located at the proximal end and the distal end of the bare stent 20.
[0091] In one or more embodiments, the bare stent 20 includes at least two rows of positioning ribs, which are spaced apart along the circumference of the bare stent 20. Each row of positioning ribs includes at least two keels 24, which are spaced apart along the axial direction of the bare stent 20, and the at least two keels 24 are located at the proximal end and the distal end of the bare stent 20, respectively.
[0092] The support members 21 at both ends of the keel 24 in the length direction are adjacent to each other along the axial direction of the bare stent 20; or there is at least one support member 21 between the two ends of the keel 24 in the length direction (excluding the support members 21 at both ends of the keel 24 in the length direction).
[0093] For the same row of positioning ribs, the length direction of at least two keels 24 is parallel to the length direction of the bare stent 20, and at least two keels 24 are opposite to each other along the length direction of the bare stent 20, thereby facilitating the operator to judge the release position of the bare stent 20 and improving the positioning accuracy of the bare stent 20.
[0094] See also Figure 8 , Figure 8 for Figure 6 The plan view of another possible implementation of the bare stent 20 is shown, in which the keel is omitted. In one or more embodiments, the support crests 122 of the support members 21 at the proximal end of the bare stent 20 are located in the same horizontal direction.
[0095] The material of the keel 24 can be the same as the material of the support member 21 or the connecting member 22. For example, the keel 24 can be a biocompatible polymer fabric, or a superelastic nickel-titanium wire, etc.
[0096] The keel 24 may be formed by twisting or braiding a single strand or a plurality of strands of superelastic material together.
[0097] The keel 24 can be formed by twisting or weaving multiple strands of superelastic material together, so that the bare stent 20 has better flexibility.
[0098] The supporting member 21 is made of superelastic shape memory material.
[0099] Generally, a general stent may need to be expanded by balloon expansion technology, which may block blood flow and cause adverse complications. At the same time, due to blood flow blocking, blood flow impacts the stent in one direction, which may also cause inaccurate positioning of the stent, resulting in displacement of the stent and poor stent implantation effect. By using a superelastic shape memory material for the support member 21, the bare stent 20 can be expanded without the need for balloon expansion technology, and the bare stent 20 can be self-expanded to fit the inner wall of the blood vessel.
[0100] The connecting member 22 and / or the supporting frame 12 are made of superelastic shape memory material.
[0101] The superelastic shape memory material enables the support frame 12, the support member 21 and the connector 22 to contract or expand radially, that is, the support frame 12, the support member 21 and the connector 22 have radial expansion ability, can be compressed under the action of external force and self-expand or recover to the initial shape through mechanical expansion after the external force is removed and maintain the initial shape, so that after implantation into the blood vessel, the radial support force can be applied to the blood vessel wall. The shape memory material includes but is not limited to at least one of nickel-titanium alloy, nitinol alloy, nickel-titanium superelastic alloy, cobalt-chromium-nickel-molybdenum alloy, copper-based shape memory alloy, iron-based shape memory alloy, etc.
[0102] In some embodiments, the wire diameter and / or rigidity of the connecting member 22 is smaller than that of the supporting member 21. Rigidity can be understood as a degree of deformation.
[0103] In one or more embodiments, the wire diameter of the connector 22 is smaller than the wire diameter of the support member 21. This arrangement is beneficial to both ensuring the radial support force of the bare stent 20 and improving the flexibility of the bare stent 20. The bare stent 20 has a smaller elongation before and after release, is easier to position, and improves the positioning accuracy of the bare stent 20.
[0104] In one or more embodiments, the connector 22 is formed by twisting or weaving together multiple strands of superelastic material. This arrangement is conducive to making the bare stent 20 have a uniform and reasonable radial support force and good axial support performance, which is conducive to avoiding the stacking and shortening of the stent; it is also conducive to avoiding the problem of new interlayer rupture caused by excessive radial support force, and it is also conducive to ensuring that the bare stent 20 has good bending flexibility and can adapt to various forms of aortic anatomical structures.
[0105] In one or more embodiments, the connector 22 is a biocompatible polymer fabric in the form of a line, a sheet, or a plurality of strands of silk threads wound together.
[0106] In one or more embodiments, the support member 21 is a biocompatible polymer fabric in the form of a line, a sheet, or a plurality of strands of silk threads wound together.
[0107] The main body coating 11 and / or the connector 22 are biocompatible polymer fabrics. Biocompatible polymer fabrics include, but are not limited to, woven or knitted polyesters, such as at least one of polyethylene terephthalate, polyethylene terephthalate, polylactide, polyglycolide and copolymers; fluorinated polymers, such as polytetrafluoroethylene, expanded or electrospun polytetrafluoroethylene and polyvinylidene fluoride; polysiloxanes, such as polydimethylsiloxane; polyurethanes, such as polyether polyurethanes, polyurethane ureas, polyether polyurethane ureas, polyurethanes containing carbonate bonds, wound nickel titanium and polyurethanes containing siloxane segments; silicone, ultra-high molecular weight polyethylene, fluorinated ethylene propylene copolymers or other suitable materials. For example, the connector 22 is made of at least one of PET, PP, PTFE or e-PTFE materials. For example, the main body coating 11 is made of at least one of PET, PP, PTFE or e-PTFE materials.
[0108] The bare stent 20 may be bent and bulged due to bending in a complex vascular anatomical structure. The bulged bare stent 20 may hinder the correct flow of blood, may cause unpredictable changes in hemodynamics, and affect the blood supply to the visceral arteries. The connector 22 is designed with a biocompatible polymer fabric, which can help improve the flexibility of the bare stent 20, help reduce the need for flexibility to ensure diseased blood vessels, better expand the true lumen 101, and restore the correct flow direction of the target blood vessel. It is helpful to reduce the problem that the bare stent 20 may be bent and bulged due to bending in a complex vascular anatomical structure, and can help reduce the interference of the bare stent 20 on the visceral arteries, which is conducive to a smoother and unimpeded blood flow to the visceral arteries.
[0109] In one or more embodiments, the connecting member 22 is made of at least one strand of superelastic material and at least one strand of biocompatible polymer fabric by twisting or weaving together.
[0110] In one or more embodiments, the connector 22 is made of a degradable material. For example, the degradable material may be at least one of magnesium, iron, zinc, a magnesium-based alloy, an iron-based alloy, a zinc-based alloy, polylactic acid, or polycarbonate.
[0111] In one or more embodiments, the local connecting element 22 is made of polymer fabric, and at least a portion of the connecting element 22 is made of superelastic shape memory material.
[0112] For possible application scenarios of the bracket system, see Fig. 9 , Fig. 9The present invention is a schematic diagram of an exemplary scenario in which a stent system according to an embodiment is used to reconstruct the thoracic aorta and the abdominal aorta. The covered stent 10 is released into the thoracic aorta, the covered stent 10 is located on the distal side of the left clavicular artery 50, and the bare stent 20 is connected to the distal end of the covered stent 10. It is expected that the covered stent 10 at least partially isolates the formed aneurysm cavity 100 and the proximal rupture 103, and the bare stent 20 is implanted in the distal aortic true lumen 101. It is expected that the bare stent 20 has the effect of isolating the distal rupture 104, which is conducive to solving the problem of distal poor perfusion, and is conducive to promoting complete thrombosis of the false lumen 102, so as to achieve a good remodeling effect of the true lumen 101; retaining the visceral arteries, reducing the long-term and second-stage prognosis, and reducing the risk of new dissections induced by the covered stent 10 at the distal end. Fig. 9 60 is the left renal artery, 70 is the right renal artery, 80 is the mesenteric artery, and 90 is the celiac trunk artery.
[0113] In some other embodiments, the covered stent 10 is located at the distal side of the brachiocephalic artery 30 or the left common carotid artery 40, and the present application no longer lists the possible application positions of the stent system in an exhaustive manner.
[0114] The above implementation modes are merely descriptions of the preferred implementation modes of the present application, and are not intended to limit the scope of the present application. Without departing from the design spirit of the present application, various modifications and improvements made to the technical solutions of the present application by ordinary engineering and technical personnel in the field shall fall within the protection scope determined by the claims of the present application.
Claims
1. A stent graft, characterized in that: include: A main body covering, wherein the main body covering comprises a proximal opening, a distal opening, and an axially extending inner cavity; A plurality of support frames, wherein the plurality of support frames are sequentially spaced apart along the axial direction of the main body coating; The support skeleton comprises a plurality of support rods connected in sequence at an angle, two adjacent angles in the circumferential direction are a support crest and a support trough respectively, the support crest and the support trough are alternately arranged along the circumference of the support skeleton, and the support crest is closer to the proximal end of the stent graft than the support trough; The support frame located at the proximal end of the stent graft is named as the first frame, at least the support trough on the first frame is fixed to the proximal end of the main body graft, and at least the support crest on the first frame extends out of the proximal end of the main body graft in a direction away from the main body graft; The first developing structure comprises at least one developing mark, at least one of the developing marks is located and fixed on the proximal side of the supporting wave valley of the first skeleton, and at least one of the developing marks is located in the area surrounded by the supporting wave valley of the first skeleton.
2. The stent graft according to claim 1, characterized in that: The proximal end of the development mark is flush with the proximal end of the main body coating.
3. The stent graft according to claim 1, characterized in that: The development mark is at least partially fixed to the supporting valley of the first frame.
4. The stent graft according to claim 1, characterized in that: The shape of the development mark is an "8" shape.
5. The stent graft according to claim 4, characterized in that: The length direction of the "8"-shaped development mark is set along the length direction of the coated support.
6. The stent graft according to claim 4, characterized in that: The "8"-shaped developing mark is formed by winding the same developing wire.
7. The stent graft according to any one of claims 1 to 6, characterized in that: The first development structure includes at least two development marks, and the at least two development marks are arranged at intervals along the circumference of the main body coating.
8. The stent graft according to any one of claims 1 to 6, characterized in that: The first development structure includes at least three development marks, and the at least three development marks are arranged at intervals along the circumference of the main body coating.
9. The stent graft according to any one of claims 1 to 6, characterized in that: It also includes a second developing structure, which is located and fixed at the distal end of the main body coating. The second developing structure includes at least two columns of developing marks, and the at least two columns of developing marks are arranged at intervals along the circumference of the main body coating.
10. The stent graft according to claim 9, characterized in that: The length direction of at least one row of the development marks and the connecting line of at least one of the development marks are parallel to the length direction of the main body coating.
11. The stent graft according to claim 9, characterized in that: The length direction of each column of the developing marks is arranged along the length direction of the main body coating, and the axial length of each column of the developing marks is 30-50 mm.
12. The stent graft according to claim 9, characterized in that: The axial length of each column of the developing marks covers at least two of the supporting skeletons at the distal end of the stent graft.
13. The stent graft according to claim 9, characterized in that: Each column of the development marks includes at least two development points, and the length direction of the line connecting the center positions of a plurality of the development points in the same column of the development marks is arranged along the length direction of the stent graft.
14. The stent graft according to claim 13, characterized in that: The support skeleton located at the distal end of the main body coating is named the first support circle; for at least two of the development points on the same column of the development mark, at least one of the development points is located on the distal side of a support wave crest of the first support circle, and the distal end of the development point is flush with the distal end of the main body coating.
15. The stent graft according to claim 13, characterized in that: The developing point is in a circular ring shape.
16. A support system, characterized in that: It comprises a bare stent and the coated stent as described in any one of claims 1-15, wherein the bare stent comprises a plurality of support skeletons connected in sequence along the axial direction so that the bare stent forms a proximal opening, a distal opening and an axially extending inner cavity, and the bare stent is used to be connected to the distal end of the coated stent, and the distal end of the coated stent and the proximal end of the bare stent have an overlapping length along the length direction; for the support skeleton located at the proximal end of the bare stent, at least one of the support crests thereon is provided with a third developing structure, and the shape of the third developing structure is an inverted "V" shape to adapt to the shape of the support crest.
